Expectations trend
FY2028 · fiscal year ending 2028-04-30 · fmp
American Outdoor Brands, Inc. (AOUT)
NASDAQConsumer DiscretionaryLeisureSnapshot 2026-11-04
$17.25-3.74%
Close 2026-11-05 · 1-day change
NASDAQConsumer DiscretionaryLeisureSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.77 → 0.74 EPS · FY ending Apr 30, 2028 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for AOUT yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Improve adjusted EBITDA margin to 6.5%-7.5% in fiscal 2027 | Profit margins are expected to improve with adjusted EBITDA margin rising to 7.5%. | Improving | adjusted EBITDA margin falls below 6.5% in FY27 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “We are maintaining our full-year guidance for net sales of $200 million to $210 million, and we are increasing our Adjusted EBITDA guidance to $14.5 million to $17.5 million.” “Fiscal '26 gross margin increased 10 basis points to 44.7%.” |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-04-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 8, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative recovery thesis, not yet a proven durable compounder: AOUT is loss-making, and recent financial performance is weak relative to its industry cohort. The long-term thesis is on watch, with management’s sales-growth priority on track but adjusted EBITDA margin progress still mixed.
AOUT is valued at a substantial premium to peers, and the valuation model has low confidence. The expectations gap is meaningful, while the evidence flags the expensive valuation as unjustified; it does not show a broader stack of valuation, business weakness, and turbulence all driving fragility.
Near term, fiscal 2027 guidance calls for net sales growth of 5% to 10% and adjusted EBITDA margins of 6.5% to 7.5%. First-quarter adjusted EBITDA improved by more than $4 million year over year, but its margin remained below the full-year target; gross margin rose to 53.0%, above management’s stated range. Recent earnings beats are positive, but performance remains weak relative to the cohort, and a guidance cut would be a meaningful setback.
Over the next few quarters, the key test is whether AOUT delivers its sales-growth plan and lifts adjusted EBITDA margin toward its fiscal 2027 target. Sector conditions are another swing factor: continued strong results and higher guidance from bellwethers could support the consumer discretionary backdrop, while misses or lower guidance could weaken it.
For the 1-to-3-year view, AOUT has signs of operational progress but remains loss-making, with mixed execution and an expensive valuation. The thesis hinges on converting revenue growth and stronger gross margin into sustained margin improvement without a guidance setback. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Sustain gross margin between 42% and 43% | Gross margin is stable near 43%. | Intact | gross margin falls below 42% | Gross margin: 52.97% FY2027-Q1; GAAP. Published target: gross margin >= 42% and <= 43%. Target period is not explicitly aligned with this observation. Sep 3, 202652.974177 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve net sales growth to $210 million in fiscal 2027 | American Outdoor Brands aims to grow sales 5% to 10% in fiscal 2027 to about $210 million. | Intact | net sales fall below $200 million in FY27 | Revenue: $37.254M FY2027-Q1; GAAP. Published target: net sales >= $200 million and <= $210 million. Target period is not explicitly aligned with this observation. Sep 3, 202637,254,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “We are maintaining our full-year guidance for net sales of $200 million to $210 million, and we are increasing our Adjusted EBITDA guidance to $14.5 million to $17.5 million.” “Net sales for fiscal 2026 were $190.5 million, a decrease of 14.3% compared to fiscal 2025.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.80 → $0.74 · observed estimates
$0.21B → $0.22B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-07-25 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-07-26 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-07-27 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-07-28 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-07-29 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-07-30 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-07-31 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-01 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-02 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-03 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-04 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-05 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-06 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-07 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-08 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-09 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-10 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-11 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-12 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-13 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-14 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-15 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-16 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-17 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-18 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-19 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-20 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-21 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-22 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-23 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-24 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-25 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-26 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-27 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-28 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-29 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-30 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-08-31 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-09-01 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-09-02 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-09-03 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-09-04 | $0.80 | $214,500,000 | 1 / 1 |
| 2026-09-05 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-06 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-07 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-08 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-09 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-10 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-11 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-12 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-13 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-14 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-15 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-16 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-17 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-18 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-19 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-20 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-21 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-22 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-23 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-24 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-25 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-26 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-27 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-28 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-29 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-09-30 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-01 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-02 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-03 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-04 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-05 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-06 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-07 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-08 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-09 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-10 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-11 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-12 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-13 | $0.77 | $213,480,500 | 1 / 1 |
| 2026-10-14 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-15 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-16 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-17 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-18 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-19 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-20 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-21 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-22 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-23 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-24 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-25 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-26 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-27 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-28 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-29 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-30 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-10-31 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-11-01 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-11-02 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-11-03 | $0.74 | $216,120,333 | 2 / 2 |
| 2026-11-04 | $0.74 | $216,120,333 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.